Farida Souami

2.3k total citations
7 papers, 264 citations indexed

About

Farida Souami is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Farida Souami has authored 7 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 1 paper in Surgery. Recurrent topics in Farida Souami's work include Advanced Breast Cancer Therapies (6 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer-related Molecular Pathways (2 papers). Farida Souami is often cited by papers focused on Advanced Breast Cancer Therapies (6 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer-related Molecular Pathways (2 papers). Farida Souami collaborates with scholars based in United States, Switzerland and France. Farida Souami's co-authors include Gabe S. Sonke, Caroline Germa, Cristian Villanueva, Lowell L. Hart, Erik Jakobsen, David Cameron, Katarína Petráková, Mariusz Bidziński, Joyce O’Shaughnessy and S. Mondal and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Farida Souami

7 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farida Souami United States 6 178 163 70 63 35 7 264
F. Mefti France 7 325 1.8× 107 0.7× 45 0.6× 22 0.3× 26 0.7× 15 392
Víctor Rodríguez-Freixinós Spain 11 194 1.1× 129 0.8× 60 0.9× 52 0.8× 84 2.4× 27 319
Laia Garrigós Spain 9 322 1.8× 177 1.1× 35 0.5× 18 0.3× 46 1.3× 35 402
James Haberberger United States 9 119 0.7× 103 0.6× 50 0.7× 17 0.3× 39 1.1× 18 204
Shigeki Tanishima Japan 10 87 0.5× 65 0.4× 90 1.3× 29 0.5× 58 1.7× 20 208
E.P. Hamilton United States 8 272 1.5× 124 0.8× 46 0.7× 14 0.2× 42 1.2× 29 317
Federica Predolini United States 9 148 0.8× 50 0.3× 35 0.5× 67 1.1× 81 2.3× 12 275
Julia Perkins Smith United States 5 152 0.9× 54 0.3× 29 0.4× 74 1.2× 87 2.5× 12 253
Sherri Damare United States 2 187 1.1× 69 0.4× 101 1.4× 46 0.7× 59 1.7× 2 292
Clare Bartos United Kingdom 9 74 0.4× 39 0.2× 64 0.9× 132 2.1× 92 2.6× 13 246

Countries citing papers authored by Farida Souami

Since Specialization
Citations

This map shows the geographic impact of Farida Souami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farida Souami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farida Souami more than expected).

Fields of papers citing papers by Farida Souami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farida Souami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farida Souami. The network helps show where Farida Souami may publish in the future.

Co-authorship network of co-authors of Farida Souami

This figure shows the co-authorship network connecting the top 25 collaborators of Farida Souami. A scholar is included among the top collaborators of Farida Souami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farida Souami. Farida Souami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Sonke, Gabe S., Lowell L. Hart, Mario Campone, et al.. (2017). Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial. Breast Cancer Research and Treatment. 167(3). 659–669. 61 indexed citations
2.
O’Shaughnessy, Joyce, Katarína Petráková, Gabe S. Sonke, et al.. (2017). Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2− advanced breast cancer in the randomized MONALEESA-2 trial. Breast Cancer Research and Treatment. 168(1). 127–134. 87 indexed citations
3.
Sonke, Gabe S., M. Campone, Frans Erdkamp, et al.. (2017). Efficacy and safety of ribociclib (LEE011) + letrozole in elderly patients with hormone receptor-positive (HR+), HER2-negative (HER2−) advanced breast cancer (ABC) in MONALEESA-2. European Journal of Cancer. 72. S1–S2. 6 indexed citations
4.
O’Shaughnessy, Joyce, Katarína Petráková, Fabrice André, et al.. (2017). Abstract P4-22-05: First-line ribociclib plus letrozole in patients with de novo HR+, HER2– advanced breast cancer (ABC): A subgroup analysis of the MONALEESA-2 trial. Cancer Research. 77(4_Supplement). P4–22. 2 indexed citations
5.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026